Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: A literature review

Research in Social and Administrative Pharmacy

Volumn 9, Issue 3, 2013, Pages 311-329

  Cheng, Yan ^a   Raisch, Dennis W ^a   Borrego, Matthew E ^a   Gupchup, Gireesh V ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

ECHO; Health disparity; Pharmaceutical care; Racial ethnic minority

Indexed keywords

ECONOMICS; ETHICS; HUMAN; HUMANISM; MINORITY GROUP; PHARMACY; REVIEW; STATISTICS; TREATMENT OUTCOME;

HUMANISM; HUMANS; MINORITY GROUPS; PHARMACEUTICAL SERVICES; TREATMENT OUTCOME;

EID: 84877830817     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2012.05.004     Document Type: Review

References (48)

1. Humes KR, Jones NA, Ramirez RR. Overview of Race and Hispanic Origin: 2010. United States Census Bureau. Available at: . Accessed 12.05.11. http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf.
2. O'Connell M.B., Korner E.J., Rickles N.M., Sias J.J. Cultural competence in health care and its implications for pharmacy. Part 1. Overview of key concepts in multicultural health care. Pharmacotherapy 2007, 27:1062-1079.
3. Healthy People 2020. Office of Disease Prevention and Health Promotion. U.S. Department of Health and Human Services. Available at: . Accessed 05.05.11. http://healthypeople.gov/2020/topicsobjectives2020/default.aspx.
4. Mullins C.D., Blatt L., Gbarayor C.M., Yang H.W., Baquet C. Health disparities: a barrier to high-quality care. Am J Health Syst Pharm 2005, 62:1873-1882.
5. Life expectancy at birth by race and sex, 1930-2007, Infoplease. Available at: . Accessed 12.12.12. http://www.infoplease.com/ipa/A0005148.html.
6. Infant mortality, American's children: key national indicators of well-being, 2011. Available at: . Accessed 12.12.12. http://www.childstats.gov/americaschildren/health2.asp.
7. Brown C.M., Nichols-English G. Dealing with patient diversity in pharmacy practice. Drug Top 1999, 143:61-70.
8. Siganga W.W., Huynh T.C. Barriers to the use of pharmacy services: the case of ethnic populations. J Am Pharm Assoc 1997, NS37:335-340.
9. Hall-Lipsy E.A., Chisholm-Burns M.A. Pharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatment. Am J Health Syst Pharm 2010, 67:462-468.
10. Levy R. Disparities in Pharmaceutical Therapy: A Major Contributor to Unequal Treatment of Ethnic and Racial Minorities 2008, National Minority Quality Forum, Available at:, Accessed 09.12.09. http://www.nmqf.org/presentations/08C1LevyR.pdf.
11. 2010 National Healthcare Disparities Report. Agency for Healthcare Research and Quality. U.S. Department of Health and Human Services. Available at: . Accessed 06.07.11. http://www.ahrq.gov/qual/qrdr10.htm.
12. Moonesinghe R., Jones W., Honore P.A., Truman B.I., Graham G. Genomic medicine and racial/ethnic health disparities: promises, perils, and the challenges for health care and public health policy. Ethn Dis 2009, 19:473-478.
13. Racial and Ethnic Disparities in Health Care. Alliance for Health Reform. Available at: . Accessed 29.06.10. http://www.allhealth.org/publications/pub_38.pdf.
14. Pharmaceutical care, Wikipedia. Available at: . Accessed 29.06.10. http://en.wikipedia.org/wiki/Pharmaceutical_care.
15. Singhal P.K., Raisch D.W., Gupchup G.V. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999, 33:1336-1355.
16. Westberg S.M., Sorensen T.D. Pharmacy-related health disparities experienced by non-English-speaking patients: impact of pharmaceutical care. J Am Pharm Assoc 2005, 45:48-54.
17. Medication therapy management, Wikipedia. Available at: . Accessed 29.06.10. http://en.wikipedia.org/wiki/Medication_therapy_management.
18. Snyder M.E., Zillich A.J., Primack B.A., et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Soc Adm Pharm 2010, 6:307-323.
19. Chisholm-Burns M.A., Graff Zivin J.S., Lee J.K., et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am J Health Syst Pharm 2010, 67:1624-1634.
20. Gunter M.J. The role of the ECHO model in outcomes research and clinical practice improvement. Am J Manag Care 1999, 5(suppl 4):S217-S224.
21. Gerber B.S., Cano A.I., Caceres M.L., et al. A pharmacist and health promoter team to improve medication adherence among Latinos with diabetes. Ann Pharmacother 2010, 44:70-79.
22. Lam A.Y. Assessing medication consultations, hypertension control, awareness, and treatment among elderly Asian community dwellers. Consult Pharm 2008, 23:795-803.
23. Lam A.Y., Chung Y. Establishing an on-site influenza vaccination service in an assisted-living facility. J Am Pharm Assoc 2008, 48:758-763.
24. Snella K.A., Canales A.E., Irons B.K., et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc 2006, 46:370-377.
25. Odegard P.S., Lam A., Chun A., Blough D., Li M.A., Wu J. Pharmacist provision of language-appropriate education for Asian patients with asthma. J Am Pharm Assoc 2004, 44:472-477.
26. Rothman R., Malone R., Bryant B., Horlen C., DeWalt D., Pignone M. The relationship between literacy and glycemic control in a diabetes disease-management program. Diabetes Educ 2004, 30:263-273.
27. Leal S., Soto M. Chronic kidney disease risk reduction in a Hispanic population through pharmacist-based disease-state management. Adv Chronic Kidney Dis 2008, 15:162-167.
28. Lai L.L. Community pharmacy-based hypertension disease-management program in a Latino/Hispanic-American population. Consult Pharm 2007, 22:411-416.
29. Jenkins R.G., Ornstein S.M., Neitert P.J., Klockars S.J., Thiedke C. Quality improvement for prevention of cardiovascular disease and stroke in an academic family medicine center: do racial differences in outcome exist?. Ethn Dis 2006, 16:132-137.
30. McPherson-Baker S., Malow R.M., Penedo F., Jones D.L., Schneideman N., Klimas N.G. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care 2000, 12:399-404.
31. Davidson M.B., Karlan V.J., Hair T.L. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000, 15:137-142.
32. Blake S.C., McMorris K., Jacobson K.L., Gzamararian J.A., Kripalani S. A qualitative evaluation of a health literacy intervention to improve medication adherence for underserved pharmacy patients. J Health Care Poor Underserved 2010, 21:559-567.
33. Gazmararian J.A., Jacobson K.L., Pan Y., Schmotzer B., Kripalani S. Effect of a pharmacy-based health literacy intervention and patient characteristics on medication refill adherence in an urban health system. Ann Pharmcother 2010, 44:80-87.
34. Chisholm M.A., Molloy L.L., Jagadeesan M., Martin B.C., DiPiro J.T. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis 2002, 12:392-397.
35. Bynum A., Hopkins D., Thomas A., Copeland N., Irwin C. The effect of telepharmacy counseling on metered-dose inhaler technique among adolescents with asthma in rural Arkansas. Telemed J E Health 2001, 7:207-217.
36. Jameson J.P., Baty P.J. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care 2010, 16:250-255.
37. Kirwin J.L., Cunningham R.J., Sequist T.D. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial. J Manag Care Pharm 2010, 16:104-113.
38. Rothman R.L., Malone R., Bryant B., et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005, 118:276-284.
39. Cohen L.A., Bonito A.J., Akin D.R., et al. Role of pharmacists in consulting with the underserved regarding toothache pain. J Am Pharm Assoc 2009, 49:38-42.
40. Caballero J., Souffrant G., Heffernan E. Development and outcomes of a psychiatric pharmacy clinic for indigent patients. Am J Health Syst Pharm 2008, 65:229-233.
41. Jaber L.A., Halapy H., Fernet M., Tummalapalli S., Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996, 30:238-343.
42. Stout J.W., White L.C., Rogers L.T., et al. The Asthma Outreach Project: a promising approach to comprehensive asthma management. J Asthma 1998, 35:119-127.
43. Kalister H., Newman R.D., Read L., Walters C., Hrachovec J., Graham E.A. Pharmacy-based evaluation and treatment of minor illnesses in a culturally diverse pediatric clinic. Arch Pediatr Adolesc Med 1999, 153:731-735.
44. Dilworth T.J., Mott D., Young H. Pharmacists' communication with Spanish-speaking patients: a review of the literature to establish an agenda for future research. Res Soc Adm Pharm 2009, 5:108-120.
45. Helper D., Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990, 47(3):533-543.
46. Montgomery A.T., Kalvemark-Sporrong S., Henning M., Tully M.P., Kettis-Lindblad A. Implementation of a pharmaceutical care service: prescriptionists', pharmacists' and doctors' views. Pharm World Sci 2007, 29:593-602.
47. Kripalani S., Henderson L.E., Jacobson T.A. Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc 2008, 83:529-535.
48. Burroughs V.J., Maxey R.W., Levy R.A. Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Med Assoc 2002, 94(suppl 10):1-26.